FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4281291327> ?p ?o ?g. }

• W4281291327 endingPage "410.e27" @default.
• W4281291327 startingPage "410.e19" @default.
• W4281291327 abstract "We sought to determine whether differences in subtype distribution and differentially expressed genes exist between African Americans (AAs) and European Americans (EAs) in patients with high-risk nonmuscle-invasive bladder cancer (NMIBC).We performed a retrospective cohort study including 26 patients (14 AAs and 12 EAs) from the University of Texas Medical Branch and the Durham Veterans Affair Health Care System from 2010 to 2020 among treatment naïve, high-risk NMIBC. Profiled gene expressions were performed using the UROMOL classification system.UROMOL racial subtype distributions were similar with class 2a being most common with 10 genes commonly upregulated in AAs compared to EAs including EFEMP1, S100A16, and MCL1 which are associated with progression to muscle-invasive bladder cancer, mitomycin C resistance, and bacillus Calmette-Guérin durability, respectively. We used single nuclei analysis to map the malignant cell heterogeneity in urothelial cancer which 5 distinct malignant epithelial subtypes whose presence has been associated with different therapeutic response prediction abilities. We mapped the expression of the 10 genes commonly upregulated by race as a function of the 5 malignant subtypes. This showed borderline (P = 0.056) difference among the subtypes suggesting AAs and EAs may be expected to have different therapeutic responses to treatments for bladder cancer. AAs were enriched with immune-related, inflammatory, and cellular regulation pathways compared to EAs, yet appeared to have reduced levels of the aggressive C3/CDH12 bladder tumor cell population.While premature, gene expression differed between AAs and EAs, supporting potential race-based etiologies for muscle-invasion, response to treatments, and transcriptome pathway regulations." @default.
• W4281291327 created "2022-05-24" @default.
• W4281291327 creator A5001816949 @default.
• W4281291327 creator A5006046348 @default.
• W4281291327 creator A5013372630 @default.
• W4281291327 creator A5015827608 @default.
• W4281291327 creator A5019668781 @default.
• W4281291327 creator A5020183452 @default.
• W4281291327 creator A5023181302 @default.
• W4281291327 creator A5033610443 @default.
• W4281291327 creator A5034460689 @default.
• W4281291327 creator A5036003731 @default.
• W4281291327 creator A5037573167 @default.
• W4281291327 creator A5052456041 @default.
• W4281291327 creator A5057044305 @default.
• W4281291327 creator A5057065367 @default.
• W4281291327 creator A5057298411 @default.
• W4281291327 creator A5059536506 @default.
• W4281291327 creator A5084204882 @default.
• W4281291327 date "2022-09-01" @default.
• W4281291327 modified "2023-10-16" @default.
• W4281291327 title "Characterizing molecular subtypes of high-risk non-muscle-invasive bladder cancer in African American patients" @default.
• W4281291327 cites W169084277 @default.
• W4281291327 cites W1711618159 @default.
• W4281291327 cites W1966900148 @default.
• W4281291327 cites W1974386050 @default.
• W4281291327 cites W1975394376 @default.
• W4281291327 cites W1992526215 @default.
• W4281291327 cites W1996994609 @default.
• W4281291327 cites W1999574084 @default.
• W4281291327 cites W2010457001 @default.
• W4281291327 cites W2019362163 @default.
• W4281291327 cites W2022566441 @default.
• W4281291327 cites W2111413836 @default.
• W4281291327 cites W2114104545 @default.
• W4281291327 cites W2130410032 @default.
• W4281291327 cites W2151781453 @default.
• W4281291327 cites W2158413364 @default.
• W4281291327 cites W2169456326 @default.
• W4281291327 cites W2426844253 @default.
• W4281291327 cites W2432815617 @default.
• W4281291327 cites W2443056117 @default.
• W4281291327 cites W2573152477 @default.
• W4281291327 cites W2611665668 @default.
• W4281291327 cites W2616305545 @default.
• W4281291327 cites W2747045298 @default.
• W4281291327 cites W2781525129 @default.
• W4281291327 cites W2785777839 @default.
• W4281291327 cites W2922818012 @default.
• W4281291327 cites W2944489822 @default.
• W4281291327 cites W2984806521 @default.
• W4281291327 cites W2990396138 @default.
• W4281291327 cites W3153221280 @default.
• W4281291327 cites W3179655120 @default.
• W4281291327 cites W3193032675 @default.
• W4281291327 cites W3206336050 @default.
• W4281291327 cites W4233280187 @default.
• W4281291327 doi "https://doi.org/10.1016/j.urolonc.2022.04.013" @default.
• W4281291327 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35618577" @default.
• W4281291327 hasPublicationYear "2022" @default.
• W4281291327 type Work @default.
• W4281291327 citedByCount "4" @default.
• W4281291327 countsByYear W42812913272022 @default.
• W4281291327 countsByYear W42812913272023 @default.
• W4281291327 crossrefType "journal-article" @default.
• W4281291327 hasAuthorship W4281291327A5001816949 @default.
• W4281291327 hasAuthorship W4281291327A5006046348 @default.
• W4281291327 hasAuthorship W4281291327A5013372630 @default.
• W4281291327 hasAuthorship W4281291327A5015827608 @default.
• W4281291327 hasAuthorship W4281291327A5019668781 @default.
• W4281291327 hasAuthorship W4281291327A5020183452 @default.
• W4281291327 hasAuthorship W4281291327A5023181302 @default.
• W4281291327 hasAuthorship W4281291327A5033610443 @default.
• W4281291327 hasAuthorship W4281291327A5034460689 @default.
• W4281291327 hasAuthorship W4281291327A5036003731 @default.
• W4281291327 hasAuthorship W4281291327A5037573167 @default.
• W4281291327 hasAuthorship W4281291327A5052456041 @default.
• W4281291327 hasAuthorship W4281291327A5057044305 @default.
• W4281291327 hasAuthorship W4281291327A5057065367 @default.
• W4281291327 hasAuthorship W4281291327A5057298411 @default.
• W4281291327 hasAuthorship W4281291327A5059536506 @default.
• W4281291327 hasAuthorship W4281291327A5084204882 @default.
• W4281291327 hasConcept C121608353 @default.
• W4281291327 hasConcept C126322002 @default.
• W4281291327 hasConcept C143998085 @default.
• W4281291327 hasConcept C2780352672 @default.
• W4281291327 hasConcept C2908647359 @default.
• W4281291327 hasConcept C502942594 @default.
• W4281291327 hasConcept C71924100 @default.
• W4281291327 hasConcept C72563966 @default.
• W4281291327 hasConcept C99454951 @default.
• W4281291327 hasConceptScore W4281291327C121608353 @default.
• W4281291327 hasConceptScore W4281291327C126322002 @default.
• W4281291327 hasConceptScore W4281291327C143998085 @default.
• W4281291327 hasConceptScore W4281291327C2780352672 @default.
• W4281291327 hasConceptScore W4281291327C2908647359 @default.
• W4281291327 hasConceptScore W4281291327C502942594 @default.
• W4281291327 hasConceptScore W4281291327C71924100 @default.

• next